Replies to post #81756 on Biotech Values

[ghmm]

GENZ:

GENZ will eventually get these issues taken care of, but meanwhile, they are losing time, money, and credibility and competitors are enjoying a tailwind.

I agree with your statement that is why a price drop on something like this (or the shareholder suit) doesn't take away from my potential interest in investing. However I'ld like to see it in the 40 range to be a much better value :-).